Experimental KRAS Vaccine for Pancreatic Cancer Shows Promise in High-Risk People
The experimental KRAS vaccine for pancreatic cancer, called mKRAS-VAX, has produced encouraging preliminary results in its first human trial. The vaccine called mKRAS-VAX has been tried out on those people who were likely to develop pancreatic cancer. It has been found that the vaccine produced a strong immune response and …
